Skip to content

Biohaven BHVN Q4 2024 Annual earnings

Reported March 3, 2025 · Before market open

EPS-$1.85Miss by $0.29
EPS estimate-$1.56

Next report

Aug 10, 2026 (In 1 week)
Revenue estimate$490.5K
EPS estimate-$0.77

Financials

Q4 2024

Income statement

See full
Operating income-$189.9M-23.6%
Net income-$186.8M-29.1%
EPS (diluted)-$1.78+4.8%

Balance sheet

See full
Cash & equivalents$102.5M-59.3%
Total debt$36.6M+18.5%
Total equity$423.4M-1.1%
Total assets$615.1M+19.9%

Cash flow

See full
Operating cash flow-$170.7M-48.6%
CapEx$49.0K-89.6%
Free cash flow-$170.8M-48.1%

Valuation & ratios

Valuation

as of 12/31/24
See full
Market cap$3.78B+10.0%
Enterprise value$3.71B+15.5%

Returns & leverage

See full
Return on equity-198.8%-760pp
Debt / equity0.1×0.0×
Current ratio3.5×-4.5×

Versus estimates

Ask the moment Biohaven reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Biohaven report Q4 2024 earnings?
Biohaven (BHVN) reported Q4 2024 earnings on March 3, 2025 before market open.
What were Biohaven's Q4 2024 revenue and EPS?
Biohaven reported eps of $-1.85 for Q4 2024.
Did Biohaven beat estimates in Q4 2024?
EPS missed the consensus estimate of $-1.56 by $0.29.
Where can I find Biohaven's Q4 2024 SEC filings?
You can read the 10-K periodic report (0001935979-25-000015) directly on SEC EDGAR. The filing index links above go to sec.gov.